Fabino Enterprises Limited operates in the pharmaceutical and wellness sectors, focusing on manufacturing, marketing, and packing consumer products for domestic and international markets. The company aims to capitalize on healthy industry prospects, leveraging its strong brand equity and a customer-centric approach to solidify its position and facilitate future growth. Its operational model combines in-house manufacturing at its Sonipat processing centre with contract manufacturing for other product ranges, ensuring flexibility and diverse offerings. The company's core business is marketing its own branded pharmaceutical formulations across India through a dedicated distribution network and sales force. Strategically, the company is focused on geographical diversification by strengthening existing client relations and creating new distribution channels in unserved cities. The Indian pharmaceutical industry, where Fabino operates, is the world's third-largest by production volume and contributes around 1.72% to the nation's GDP.;
MD/CEO
Aditya Mahavir Jain